Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.5150
+0.0240 (4.89%)
At close: Nov 3, 2026, 4:00 PM EST
0.5186
+0.0036 (0.70%)
After-hours: Nov 3, 2026, 7:49 PM EST
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $6.48 million as of November 3, 2026. It is the 43,650th most valuable company in the world and the 5,826th biggest in the United States. Its market cap has decreased by 20.49% in one year.
Market Cap
6.48M
Enterprise Value
-34.75M
1-Year Change
-20.49%
Global Rank
Country Rank
#5,826 United States
Category
ChartMarket Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $6.48M, a decrease of -65.75%. That is a compound annual growth rate of -21.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 6.48M | 8.69% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Exicure | 6.68M |
| Enveric Biosciences | 6.49M |
| CNS Pharmaceuticals | 6.42M |
| FibroBiologics | 6.40M |
| Processa Pharmaceuticals | 6.20M |
| Alzamend Neuro | 6.03M |
| XTL Biopharmaceuticals | 5.90M |
| Senti Biosciences Holdings | 5.86M |